AC Immune SA Files April 2025 6-K Report
Ticker: ACIU · Form: 6-K · Filed: Apr 30, 2025 · CIK: 1651625
| Field | Detail |
|---|---|
| Company | Ac Immune SA (ACIU) |
| Form Type | 6-K |
| Filed Date | Apr 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-K, foreign-private-issuer
Related Tickers: ACIU
TL;DR
AC Immune SA filed their April 6-K, nothing major but it's now part of their F-3/S-8 filings.
AI Summary
AC Immune SA filed a Form 6-K on April 30, 2025, reporting for the month of April 2025. This filing is incorporated by reference into their existing registration statements on Form F-3 and Form S-8. The company is based in Lausanne, Switzerland, and operates in the pharmaceutical preparations sector.
Why It Matters
This filing provides routine updates and ensures ongoing compliance with SEC regulations for foreign private issuers, potentially impacting investor awareness of the company's reporting status.
Risk Assessment
Risk Level: low — This is a routine 6-K filing for a foreign private issuer, typically containing updates or information not requiring a more comprehensive filing.
Key Players & Entities
- AC Immune SA (company) — Registrant
- 001-37891 (company) — Commission file number
- 333-227016 (company) — Form F-3 registration statement file number
- 333-249655 (company) — Form F-3 registration statement file number
- 333-277940 (company) — Form F-3 registration statement file number
- 333-213865 (company) — Form S-8 registration statement file number
- 333-216539 (company) — Form S-8 registration statement file number
- 333-233019 (company) — Form S-8 registration statement file number
FAQ
What type of report is AC Immune SA filing?
AC Immune SA is filing a Form 6-K, which is a Report of Foreign Private Issuer.
For what period is this Form 6-K reporting?
This Form 6-K is reporting for the month of April, 2025.
What is the commission file number for AC Immune SA?
The commission file number for AC Immune SA is 001-37891.
Which registration statements will this 6-K filing be incorporated into?
This 6-K filing will be incorporated by reference into AC Immune SA's registration statements on Form F-3 (File Nos. 333-227016, 333-249655 and 333-277940) and Form S-8 (File Nos. 333-213865, 333-216539 and 333-233019).
Where is AC Immune SA's principal executive office located?
AC Immune SA's principal executive office is located at EPFL Innovation Park Building B, 1015 Lausanne, Switzerland.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 30, 2025 regarding AC Immune SA (ACIU).